UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ...
– Reached an agreement to be acquired by Alexion; transaction expected to close in first half of 2020 – –...
BLUE BELL, Pa., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), a...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION...
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
SHAREHOLDER ALERT: WeissLaw LLP Investigates Achillion Pharmaceuticals, Inc. PR Newswire NEW YORK, Oct. 18...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC...
Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Achillion Pharmaceuticals, Inc. has obtained a Fair Price in its sale to...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.